PagayaApplied sciences Ltd. PGY is scheduled to launch its first-quarter 2024 outcomes on Might 9, earlier than market open.
The corporate’s earnings shock historical past has not been spectacular. It missed the Zacks Consensus Estimate in three of the trailing 4 quarters and met in a single occasion, delivering a destructive earnings shock of 108.3%, on common.
Pagaya Applied sciences Ltd. Worth and EPS Shock
Pagaya Technologies Ltd. price-eps-surprise | Pagaya Applied sciences Ltd. Quote
Q1 Expectations
The Zacks Consensus Estimate for the highest line is pegged at $229.5 million, indicating a 23% improve from the year-ago quarter’s precise.
The rise in revenues is prone to have been attributable to an increase in payment revenues that represents many of the whole revenues. Progress in payment revenues much less manufacturing prices are prone to have been pushed by the corporate’s strong fee-generating enterprise.
The Zacks Consensus Estimate for earnings is pegged at 16 cents per share, indicating a rise of greater than 100% from the year-ago quarter’s precise. We count on development within the backside line to have been pushed by disciplined price administration that improves working effectivity.
What Our Mannequin Says
Our confirmed mannequin doesn’t conclusively predict an earnings beat for PGY this time round. The mix of a constructive Earnings ESP and a Zacks Rank #1 (Robust Purchase), 2 (Purchase) or 3 (Maintain) will increase the chances of an earnings beat. However that’s not the case right here. You may uncover one of the best shares earlier than they’re reported with our Earnings ESP Filter.
Pagaya has an Earnings ESP of -29.79% and a Zacks Rank of three at current.
Shares to Take into account
Listed here are a number of shares from the broader Business Services sector, which, in keeping with our mannequin, have the appropriate mixture of components to beat on earnings this season.
Stantec STN: The Zacks Consensus Estimate for the corporate’s first-quarter 2024 revenues is pegged at $999.1 million, implying 10% year-over-year development. The consensus estimate for earnings is pegged at 83 cents per share, suggesting a 16.7% rise from the year-ago quarter’s precise. The corporate has a median shock of 4.8%.
STN presently has an Earnings ESP of +3.18% and a Zacks Rank of three. The corporate is scheduled to declare its first-quarter outcomes on Might 8. You may see the complete list of today’s Zacks #1 Rank stocks here.
Maximus MMS: The Zacks Consensus Estimate for the corporate’s second-quarter fiscal 2024 revenues is pegged at $1.3 million, implying 10% development from the year-ago quarter’s reported determine. The consensus mark for earnings is pegged at $1.3 per share, suggesting a rise of 63.8% from the year-ago quarter’s precise. The corporate has a median destructive shock of seven%.
MMS presently has an Earnings ESP of +1.53% and a Zacks Rank of two. The corporate is scheduled to put up its first-quarter outcomes on Might 8.
Keep on high of upcoming earnings bulletins with the Zacks Earnings Calendar.
The place Will Shares Go…
If Biden Wins? If Trump Wins?
The solutions could shock you.
Since 1950, even after destructive midterm years, the market has by no means had a decrease presidential election 12 months. With voters energized and engaged, the market has been virtually unrelentingly bullish irrespective of which social gathering wins!
Now’s the time to obtain Zacks’ free Particular Report with 5 shares that provide excessive upside for each Democrats and Republicans…
1. Medical producer has gained +11,000% within the final 15 years.
2. Rental firm is completely crushing its sector.
3. Power powerhouse plans to develop its already massive dividend by 25%.
4. Aerospace and protection standout simply landed a doubtlessly $80 billion contract.
5. Large Chipmaker is constructing large crops within the U.S.
Hurry, Download Special Report FREE >>
Stantec Inc. (STN) : Free Stock Analysis Report
Maximus, Inc. (MMS) : Free Stock Analysis Report
Pagaya Technologies Ltd. (PGY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
